OpenLegislation

The National Health Service (Pharmaceutical Services) (Scotland) Amendment Regulations 2018

S.S.I. 2018/68 · Made 15 February 2018

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

National Health Service

Made 15th February 2018

Laid before the Scottish Parliament 19th February 2018

Coming into force 1st April 2018

The Scottish Ministers make the following Regulations in exercise of the powers conferred by section 27(1)(cc) and (1A)(a) of the National Health Service (Scotland) Act 1978f1, and all other powers enabling them to do so.

Annotations to the whole text

Footnotes

f1

1978 c.29; section 27(1)(cc) was inserted by the Medicinal Products: Prescription by Nurses etc. Act 1992 (c.28), section 3, and amended by the Health and Social Care Act 2001 (c.15) (“the 2001 Act”), section 44(2); section 27(1A)(a) was inserted by the 2001 Act, section 44(3), and amended by the Health and Social Care Act 2012 (c.7), section 213(7) and S.I. 2003/1590; section 108(1) contains definitions of “prescribed” and “regulations” relevant to the exercise of the statutory powers under which these Regulations are made. The functions of the Secretary of State were transferred to the Scottish Ministers by virtue of section 53 of the Scotland Act 1998 (c.46).

Contents

  1. 1Citation and commencement
  2. 2Amendment of the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009
  3. 3Amendment of the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009
  4. Signature
  5. Explanatory note

1Citation and commencement

These Regulations may be cited as the National Health Service (Pharmaceutical Services) (Scotland) Amendment Regulations 2018 and come into force on 1st April 2018.

2Amendment of the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009

The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009f1 are amended as follows.

3Amendment of the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009

In regulation 2(1) (interpretation and application)—

(a)

for the definition of “advanced electronic signature” substitute—

  • ““advanced electronic signature” means an advanced electronic signature within the meaning given in Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council of 23 July 2014 on electronic identification and trust services for electronic transactions in the internal market and repealing Directive 1999/93/ECf1;”;

(b)

after the definition of “electronic prescription form” insert—

  • ““electronic signature” has the meaning given to it by section 7(2) of the Electronic Communications Act 2000f2;”;

(c)

after the definition of “optometrist independent prescriber” insert—

  • ““paramedic independent prescriber” means a person—

    1. (a)

      registered in Part 8 of the register maintained under article 5 of the Health and Social Work Professions Order 2001f3; and

    2. (b)

      against whose name in that register is recorded an annotation signifying that the person is qualified to order drugs, medicines and appliances as a paramedic independent prescriber;”; and

(d)

in the definition of “prescriber”—

(i)

at the end of paragraph (fa) omit “or”; and

(ii)

after paragraph (fa) insert—

“(fb)

a paramedic independent prescriber, or”.

Signature

AILEEN CAMPBELL

Authorised to sign by the Scottish Ministers

St Andrew’s House,

Edinburgh

15th February 2018

Explanatory note

(This note is not part of the Regulations)

These Regulations amend the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 (“the 2009 Regulations”). Regulation 3 extends the definition of “prescriber” in regulation 2(1) of the 2009 Regulations by the insertion of a new category of independent prescriber, namely paramedic independent prescribers and also adds into that regulation a definition of “paramedic independent prescriber”.

Regulation 3 additionally amends the definition of “advanced electronic signature” also in regulation 2(1) of the 2009 Regulations to reflect the definition in article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council of 23rd July 2014 on electronic identification and trust services for electronic transactions in the internal market and repealing Directive 1999/93/EC and makes a consequential change by adding a new definition of “electronic signature”.